(2S,3S,4S,5R,6R)-6-{3-[(4-carboxy-3-hydroxy-5-methylphenoxy)carbonyl]-4-hydroxy-2-pentadecylphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

ID: ALA5279972

Max Phase: Preclinical

Molecular Formula: C36H50O13

Molecular Weight: 690.78

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCCCCCc1c(O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)ccc(O)c1C(=O)Oc1cc(C)c(C(=O)O)c(O)c1

Standard InChI:  InChI=1S/C36H50O13/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-23-26(48-36-31(41)29(39)30(40)32(49-36)34(44)45)18-17-24(37)28(23)35(46)47-22-19-21(2)27(33(42)43)25(38)20-22/h17-20,29-32,36-41H,3-16H2,1-2H3,(H,42,43)(H,44,45)/t29-,30-,31+,32-,36-/m0/s1

Standard InChI Key:  XGBVMNCZGOFCJQ-BHEHYUOBSA-N

Molfile:  

 
     RDKit          2D

 49 51  0  0  0  0  0  0  0  0999 V2000
   -3.5732    1.2365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5732    0.4115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8587   -0.0009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1441    0.4115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1441    1.2365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8587    1.6489    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4299    1.6488    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4299    2.4736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1433    2.8863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1433    3.7085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4288    4.1211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7125    3.7121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7125    2.8877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0030    4.1245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0030    4.9494    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7112    3.7121    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4256    4.1245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4256    4.9494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1381    5.3599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8543    4.9473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8543    4.1266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1427    3.7103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5670    5.3597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5670    6.1845    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2812    4.9473    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1381    6.1847    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4288    4.9459    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4299   -0.0008    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8587   -0.8257    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2875   -0.0008    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2875    1.6488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0017    1.2365    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2875    2.4736    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0017    2.4754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0017    1.6507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7159    1.2382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7159    0.4135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4302    0.0010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4302   -0.8234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1445   -1.2359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1445   -2.0607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8588   -2.4730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8588   -3.2980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5731   -3.7104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5731   -4.5351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2875   -4.9476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2875   -5.7723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0017   -6.1847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5685    3.7142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  5  7  1  6
  7  8  1  0
  9  8  2  0
 10  9  1  0
 11 10  2  0
 12 11  1  0
 13 12  2  0
  8 13  1  0
 12 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 21 20  1  0
 22 21  2  0
 17 22  1  0
 20 23  1  0
 23 24  2  0
 23 25  1  0
 19 26  1  0
 11 27  1  0
  4 28  1  6
  3 29  1  1
  2 30  1  6
  1 31  1  1
 31 32  1  0
 31 33  2  0
 13 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
 44 45  1  0
 45 46  1  0
 46 47  1  0
 47 48  1  0
 21 49  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5279972

    ---

Associated Targets(Human)

HPSE Tchem Heparanase (634 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16-F10 (4610 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 690.78Molecular Weight (Monoisotopic): 690.3251AlogP: 5.23#Rotatable Bonds: 20
Polar Surface Area: 220.51Molecular Species: ACIDHBA: 11HBD: 7
#RO5 Violations: 4HBA (Lipinski): 13HBD (Lipinski): 7#RO5 Violations (Lipinski): 4
CX Acidic pKa: 2.56CX Basic pKa: CX LogP: 8.98CX LogD: 2.01
Aromatic Rings: 2Heavy Atoms: 49QED Weighted: 0.05Np Likeness Score: 0.97

References

1. Jia L, Ma S..  (2016)  Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.,  121  [PMID:27240275] [10.1016/j.ejmech.2016.05.052]

Source